39th International Conference on Pharmacoepidemiology and Therapeutic Risk Management

The 39th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE) was held in Halifax, Nova Scotia, Canada, on August 23-27, 2023. A variety of Sentinel-related work was featured, including presentations, posters, and more.

Symposia 

• Introducing CoLab: The Evolution of US-Canada International Collaboration on Drug Safety and Effectiveness

Lightning Presentations 

• Characterizing Medication Use Patterns Among Pregnant and Non-Pregnant Patients with COVID-19 in the Sentinel System

Spotlight Posters 

• Utilization of Beta-blockers Among the Pediatric Population in the United States: A Study in the FDA’s Sentinel System from 2008 to 2022

Oral Presentations 

• Hospitalized Arterial and Venous Thrombotic Events in Patients Diagnosed in the Ambulatory Setting with COVID-19 Compared to Influenza
• Investigating Potential Differences in the Safety Profiles of Biosimilars Relative to Originator Products Using a Tree-Based Scan Statistic
• Principled Approaches to Handle Partially Observed Confounder Data from Electronic Health Records: A Plasmode Simulation Study
• Triple Challenges – Small Sample Sizes in Both Exposure and Control Groups When Scanning Rare Maternal Outcomes in Signal Identification: A Simulation Study
• Variation in Mother-Infant Linkage Rates by Jurisdiction in U.S. Medicaid Data

Posters 

• Association Between Race and COVID-19 Outcomes in the United States (2020-2021)
• Diversifying the FDA’s Sentinel System with Rigorous Quality Inclusion Rules for the U.S. Medicaid Population
• Expanding Capabilities for Unapproved Cannabis-Derived Product Surveillance in the United States, TriNetX, July 1, 2018 – June 30, 2022
• Exploring the Use of Electronic Health Records (EHR) Data for Active Safety Surveillance of Epidiolex in PCORnet, July 1, 2018- July 1, 2022
• High Dose Dexamethasone for COVID-19 Not Common in a Large US Hospital Network
• NLP Detection of Mortality Information from Publicly Available Data Using Deep Learning Modeling
• Percutaneous Transluminal Septal Myocardial Ablation and Common Procedural Complications Before and After the Approval of Ablysinol
• Racial and Ethnic Differences in Hospitalized and Critical COVID-19 Treatment, January 2021-April 2022
• Using Real-World Data to Evaluate Comparative Effectiveness Cohorts of Azithromycin Relative to Roflumilast in Individuals with Uncontrolled Chronic Obstructive Pulmonary Disease
• Utilization of Gonadotropin-Releasing Hormone Agonist Products in Adolescents

More information on the conference can be found here.